EUVIMEDEUVIMED entdecken
Crossref

New Isoxazole Derivatives: Design, Synthesis, Crystal Structure, Antimicrobial Assessments, and In Silico Studies

Aziz Arzine, Soumia A. Assou, Fatima Z. Guerguer, Khalid Boujdi, Yassine Rhazi, Najoua Barghady, Mohammed Chalkha, Asmae Nakkabi, Karim Chkirate, Joel T. Mague, Mohamed Bakhouch, Samir Chtita und 3 weitere

ChemistrySelect · 2025-09 · 10 (33)

DOI: 10.1002/slct.202405455 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 29.08.2025. Verfasst von Aziz Arzine und 14 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The present work reports the synthesis of new isoxazole derivatives as well as assessments of their antimicrobial activity through both in vitro and in silico approaches. The structures of all new compounds were determined by spectroscopic methods, including FT‐IR and NMR ( 1 H, 13 C), and unambiguously confirmed by mass spectrometry (MS) and single‐crystal X‐ray diffraction (XRD). The new isoxazoles were tested in vitro for their antimicrobial activity and the results indicate that they exhibit significant inhibitory activity against the tested microbial strains compared to the reference antibiotics. Notably, 4e , 4g , and 4h exhibited significantly higher activity against Candida albicans compared to their activity against Escherichia coli and Bacillus subtilis . Minimum inhibitory concentration (MIC) measurements showed that the compounds were effective against C. albicans , B. subtilis , and E. coli , with MIC values ranging from 6 to 60 µg/mL, 10 to 80 µg/mL, and 30 to 80 µg/mL, respectively. Furthermore, molecular docking studies performed on the isoxazoles revealed significant affinities for the three target receptors ( 1KZN , 1OF0 , and 1EAG ) compared to standard antibiotics. The molecular dynamics simulation analysis of the 1KZN‐4e , 1OF0‐4e , and 1EAG‐4e complexes revealed a high degree of stability between the ligand 4e and the target proteins. In addition, in silico predictions indicate that the isoxazole compounds were analyzed on the basis of their similarity to existing drugs and their ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties. These analyses show favorable pharmacokinetic profiles with no evidence of toxicity.

Zitieren

APA

Arzine, A., Assou, S. A., Guerguer, F. Z., Boujdi, K., Rhazi, Y., Barghady, N., Chalkha, M., Nakkabi, A., Chkirate, K., Mague, J. T., Bakhouch, M., Chtita, S., Mabrouk, E. H., Hassouni, M. E., & Yazidi, M. E. (2025). New Isoxazole Derivatives: Design, Synthesis, Crystal Structure, Antimicrobial Assessments, and In Silico Studies. ChemistrySelect, 10(33). https://doi.org/10.1002/slct.202405455

Vancouver

Arzine A, Assou SA, Guerguer FZ, Boujdi K, Rhazi Y, Barghady N, et al. New Isoxazole Derivatives: Design, Synthesis, Crystal Structure, Antimicrobial Assessments, and In Silico Studies. ChemistrySelect. 2025;10(33). doi:10.1002/slct.202405455

BibTeX
@article{Arzine2025,
  author = {Arzine, Aziz and Assou, Soumia A. and Guerguer, Fatima Z. and Boujdi, Khalid and Rhazi, Yassine and Barghady, Najoua and Chalkha, Mohammed and Nakkabi, Asmae and Chkirate, Karim and Mague, Joel T. and Bakhouch, Mohamed and Chtita, Samir and Mabrouk, El Houssine and Hassouni, Mohammed El and Yazidi, Mohamed El},
  title = {New Isoxazole Derivatives: Design, Synthesis, Crystal Structure, Antimicrobial Assessments, and In Silico Studies},
  journal = {ChemistrySelect},
  year = {2025},
  volume = {10},
  number = {33},
  doi = {10.1002/slct.202405455}
}
Kostenlos starten →